Aurinia Pharmaceuticals Inc. (AUPH) › Weighted Average Diluted SharesAurinia Pharmaceuticals Inc. (AUPH) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 118.47M2021-12-31: 129.37M2022-12-31: 141.91M2023-12-31: 143.24M2024-12-31: 146.19M2025-12-31: 138.70M138.70M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31138.70M-5.1%2026-02-26From 2025-01-012024-12-31146.19M+2.1%2026-02-26From 2024-01-012023-12-31143.24M+0.9%2026-02-26From 2023-01-012022-12-31141.91M+9.7%2025-02-27From 2022-01-012021-12-31129.37M+9.2%2024-02-15From 2021-01-012020-12-31118.47M—2023-02-28From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)